Bertoluci Marcello Casaccia, Pimazoni-Netto Augusto, Pires Antonio Carlos, Pesaro Antonio Eduardo, Schaan Beatriz D, Caramelli Bruno, Polanczyk Carisi Anne, Júnior Carlos Vicente Serrano, Gualandro Danielle M, Malerbi Domingos Augusto, Moriguchi Emilio, Borelli Flavio Antonio de Oliveira, Salles João Eduardo Nunes, Júnior José Mariani, Rohde Luis Eduardo, Canani Luis H, Cesar Luiz Antonio Machado, Tambascia Marcos, Zanella Maria Tereza, Gus Miguel, Scheffel Rafael Selbach, Dos Santos Raul Dias
Faculdade de Medicina da Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Universidade Federal de São Paulo, São Paulo, Brazil.
Diabetol Metab Syndr. 2014 May 20;6:58. doi: 10.1186/1758-5996-6-58. eCollection 2014.
There is a very well known correlation between diabetes and cardiovascular disease but many health care professionals are just concerned with glycemic control, ignoring the paramount importance of controlling other risk factors involved in the pathogenesis of serious cardiovascular diseases. This Position Statement from the Brazilian Diabetes Society was developed to promote increased awareness in relation to six crucial topics dealing with diabetes and cardiovascular disease: Glicemic Control, Cardiovascular Risk Stratification and Screening Coronary Artery Disease, Treatment of Dyslipidemia, Hypertension, Antiplatelet Therapy and Myocardial Revascularization. The issue of what would be the best algorithm for the use of statins in diabetic patients received a special attention and a new Brazilian algorithm was developed by our editorial committee. This document contains 38 recommendations which were classified by their levels of evidence (A, B, C and D). The Editorial Committee included 22 specialists with recognized expertise in diabetes and cardiology.
糖尿病与心血管疾病之间存在一种广为人知的关联,但许多医疗保健专业人员只关注血糖控制,而忽视了控制严重心血管疾病发病机制中其他危险因素的至关重要性。巴西糖尿病协会的这份立场声明旨在提高对涉及糖尿病和心血管疾病的六个关键主题的认识:血糖控制、心血管风险分层与冠状动脉疾病筛查、血脂异常治疗、高血压、抗血小板治疗以及心肌血运重建。糖尿病患者使用他汀类药物的最佳算法问题受到了特别关注,我们的编辑委员会制定了一种新的巴西算法。本文件包含38条建议,这些建议根据证据水平(A、B、C和D)进行了分类。编辑委员会包括22位在糖尿病和心脏病学方面具有公认专业知识的专家。